A Study to Evaluate Efficacy and Safety of the Combination of SCTA01 & SCTA01C in Outpatients With COVID-19

DRUG: SCTA01 and SCTA01C
DRUG: Placebo

PHASE1,PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped The study was withdraw due to the fast spread of Omicron variant worldwide

Conditions

Sinocelltech Ltd.